Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
41
RARE Quote, Financials, Valuation and Earnings
Last price:
$37.68
Seasonality move
:
11.76%
Day range:
$38.54 - $39.42
52-week range:
$29.59 - $60.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.28x
P/B ratio:
14.08x
Volume:
588.3K
Avg. volume:
940.8K
1-year change:
-9.08%
Market cap:
$3.6B
Revenue:
$560.2M
EPS (TTM):
-$6.34
Earnings Data
Next earnings date for RARE
May 06
2025
Most recent earnings per share
-$1.39
Missed by $0.12
(Feb 13/2025)
Consensus Estimate
-$1.27
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RARE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/01/2025 | Q2 | $162.4M | -- | -- | -$1.39 | -- |
| 05/06/2025 | Q1 | $144.5M | -- | -- | -$1.64 | -- |
| 02/13/2025 | Q4 | $158.7M | $164.9M | -$1.39 | -$1.27 | -$0.12 |
| 11/05/2024 | Q3 | $135.2M | $139.5M | -$1.40 | -$1.47 | $0.07 |
| 08/01/2024 | Q2 | $123.2M | $147M | -$1.52 | -$1.63 | $0.11 |
| 05/02/2024 | Q1 | $116.4M | $108.8M | -$2.03 | -$1.72 | -$0.31 |
| 02/15/2024 | Q4 | $121M | $127.4M | -$1.52 | -$1.61 | $0.09 |
| 11/02/2023 | Q3 | -- | -- | -$2.23 | -$2.01 | -$0.22 |
| 08/03/2023 | Q2 | -- | -- | -$2.25 | -$2.02 | -$0.23 |
| 05/04/2023 | Q1 | -- | -- | -$2.33 | -$1.61 | -$0.72 |
| 02/16/2023 | Q4 | -- | -- | -$2.16 | -$1.80 | -$0.36 |
| 11/02/2022 | Q3 | -- | -- | -$3.50 | -$2.40 | -$1.10 |
| 07/28/2022 | Q2 | -- | -- | -$2.26 | -$1.64 | -$0.62 |
| 05/05/2022 | Q1 | -- | -- | -$2.19 | -$1.78 | -$0.41 |
| 02/10/2022 | Q4 | -- | -- | -$1.79 | -$1.19 | -$0.60 |
| 11/02/2021 | Q3 | -- | -- | -$1.08 | -$1.10 | $0.02 |
| 08/02/2021 | Q2 | -- | -- | -$1.81 | -$1.05 | -$0.76 |
| 05/04/2021 | Q1 | -- | -- | -$2.03 | -$1.29 | -$0.74 |
| 02/11/2021 | Q4 | -- | -- | -$0.37 | -$1.14 | $0.77 |
| 10/27/2020 | Q3 | -- | -- | -$1.13 | -$1.07 | -$0.07 |
| 07/30/2020 | Q2 | -- | -- | $0.41 | -$1.73 | $2.14 |
| 05/06/2020 | Q1 | -- | -- | -$2.05 | -$1.68 | -$0.37 |
| 02/13/2020 | Q4 | -- | -- | -$1.62 | -$1.53 | -$0.09 |
| 11/05/2019 | Q3 | -- | -- | -$1.96 | -$1.55 | -$0.41 |
| 08/01/2019 | Q2 | -- | -- | -$1.90 | -$1.59 | -$0.30 |
| 05/06/2019 | Q1 | -- | -- | -$1.82 | -$1.67 | -$0.15 |
| 02/19/2019 | Q4 | -- | -- | -$1.73 | -$1.87 | $0.14 |
| 11/05/2018 | Q3 | -- | -- | -$1.74 | -$1.99 | $0.25 |
| 08/02/2018 | Q2 | -- | -- | -$1.87 | -$2.13 | $0.26 |
| 05/07/2018 | Q1 | -- | -- | -$2.07 | -$0.87 | -$1.20 |
| 02/20/2018 | Q4 | -- | -- | -$2.27 | -$1.99 | -$0.28 |
| 11/02/2017 | Q3 | -- | -- | -$1.87 | -$1.87 | $0.00 |
| 07/27/2017 | Q2 | -- | -- | -$1.72 | -$1.71 | -$0.01 |
| 05/08/2017 | Q1 | -- | -- | -$1.63 | -$1.71 | $0.08 |
| 02/16/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -- | -- | -- |
| 08/13/2015 | Q2 | -- | -- | -- | -- | -- |
Ultragenyx Pharmaceutical Earnings Questions
-
How Much did Ultragenyx Pharmaceutical Generate in Revenue Last Quarter?
Ultragenyx Pharmaceutical reported $164.9M worth of top line sales in its most recent quarter.
-
Did Ultragenyx Pharmaceutical Beat Earnings Last Quarter?
Ultragenyx Pharmaceutical announced earnings per share of -$1.39 which represents a miss of analyst forecast a -$1.27 per share.
-
Is Ultragenyx Pharmaceutical Profitable?
Ultragenyx Pharmaceutical reported $148M that represents $1.55 per share over the last quarter.
-
What is the Analyst Consensus for Ultragenyx Pharmaceutical EPS Next Year?
Ultragenyx Pharmaceutical's earnings are forecast to decrease from -$6.29 per share to -$6.17 per share next year representing a decrease of -14.5%.
-
When is Ultragenyx Pharmaceutical's Earnings Date?
Currently, Ultragenyx Pharmaceutical has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 41.7% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is up 0.05% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 1.65% over the past day.
